LIDOCAINE 23% / TETRACAINE 7%- lidocaine 23% / tetracaine 7% ointment 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

LIDOCAINE 23% / TETRACAINE 7%

Directions for use

zc

Sincerus Florida, LLC. Adverse reactions

ad

Active, inactive

da

NDC 72934- 5040-4 LIDOCAINE USP 23% / TETRACAINE USP 7%. Ointment 120gm

zc

LIDOCAINE 23% / TETRACAINE 7% 
lidocaine 23% / tetracaine 7% ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-5140
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE23 g  in 100 g
TETRACAINE (UNII: 0619F35CGV) (TETRACAINE - UNII:0619F35CGV) TETRACAINE7 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-5140-4120 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/17/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/17/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-5140)

Revised: 5/2019
Document Id: 8916a5aa-7234-4810-e053-2a95a90a7ef1
Set id: 8916a5aa-7233-4810-e053-2a95a90a7ef1
Version: 1
Effective Time: 20190517
 
Sincerus Florida, LLC